Baerbel Rohrer to Choroidal Neovascularization
This is a "connection" page, showing publications Baerbel Rohrer has written about Choroidal Neovascularization.
Connection Strength
3.334
-
Connecting the innate and adaptive immune responses in mouse choroidal neovascularization via the anaphylatoxin C5a and ?dT-cells. Sci Rep. 2016 Mar 31; 6:23794.
Score: 0.500
-
Local production of the alternative pathway component factor B is sufficient to promote laser-induced choroidal neovascularization. Invest Ophthalmol Vis Sci. 2015 Jan 15; 56(3):1850-63.
Score: 0.460
-
A comparative analysis of C57BL/6J and 6N substrains; chemokine/cytokine expression and susceptibility to laser-induced choroidal neovascularization. Exp Eye Res. 2014 Dec; 129:18-23.
Score: 0.452
-
The complement regulatory protein CD59: insights into attenuation of choroidal neovascularization. Adv Exp Med Biol. 2014; 801:435-40.
Score: 0.428
-
Systemic human CR2-targeted complement alternative pathway inhibitor ameliorates mouse laser-induced choroidal neovascularization. J Ocul Pharmacol Ther. 2012 Aug; 28(4):402-9.
Score: 0.375
-
The alternative pathway is required, but not alone sufficient, for retinal pathology in mouse laser-induced choroidal neovascularization. Mol Immunol. 2011 Mar; 48(6-7):e1-8.
Score: 0.349
-
A targeted inhibitor of the complement alternative pathway reduces RPE injury and angiogenesis in models of age-related macular degeneration. Adv Exp Med Biol. 2010; 703:137-49.
Score: 0.324
-
A targeted inhibitor of the alternative complement pathway reduces angiogenesis in a mouse model of age-related macular degeneration. Invest Ophthalmol Vis Sci. 2009 Jul; 50(7):3056-64.
Score: 0.306
-
Anaphylatoxin Signaling in Retinal Pigment and Choroidal Endothelial Cells: Characteristics and Relevance to Age-Related Macular Degeneration. Adv Exp Med Biol. 2018; 1074:45-51.
Score: 0.141